2013 OutlookBased on current market and operating conditions, estimated business expansion and forecasted Chang'an Hospital financial results, Concord Medical expects to generate total net revenues in an estimated range of RMB930 million to RMB975 million in 2013, which would represent a 40% to 47% increase from 2012. The revenues from network business and hospital business as percentages to total revenues are expected to be approximately 55% and 45% in 2013, respectively. Finally, the Company is targeting to start construction of the specialty cancer oncology hospital in Guangzhou in 2013.
These estimates are based on current market and operating conditions, are subject to change, and may be impacted positively or negatively by factors outside the Company's control, including but not limited to macroeconomic events in the markets in which the Company operates. See "Safe Harbor Statement" below for additional information regarding forward-looking statements.
Conference Call InformationConcord Medical's management will hold an earnings conference call at 8:00 a.m. Eastern Daylight Time on May 22, 2013 (8:00 p.m. Beijing/Hong Kong time on May 22, 2013).
Dial-in details for the earnings conference call are as follows:U.S. Toll Free:
1-866-519-4004U.K. Toll Free:
65 67239381China Toll Free:
400-620-8038 / 800-819-0121Hong Kong Toll Free:
CCMA replay of the conference call may be accessed by phone at the following numbers for 7 days: U.S. Toll Free:
+61 2 8199 0299Conference ID:
71197242Additionally, a live and archived webcast of this conference call will be available at http://ir.concordmedical.com/.
About Concord MedicalConcord
|SOURCE Concord Medical Services Holdings Limited|
Copyright©2012 PR Newswire.
All rights reserved